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Research
In recent years, there has been increasing con-
cern about exposure to ubiquitous environ-
mental pollutants, including chemicals with 
endocrine-disrupting effects, and their impact 
on human health (Amaral Mendes 2002; 
Cheek et al. 1998; McLachlan 2001). This 
concern was highlighted by a recent survey of 
1,455 adults revealing a potential link between 
exposure to environmental pollutants [e.g., 
bisphenol A (BPA)] and the occurrence of 
diseases (Lang et al. 2008). In the context of 
allergic diseases, including asthma, a recent 
meta-analysis of several epidemiologic studies   
in adult populations, mostly in occupational 
settings, showed associations between poly-
vinyl chloride (PVC) fume exposure and respi-
ratory symptoms (Jaakkola and Knight 2008). 
Results from studies of children also revealed 
an association between PVC surface materi-
als in the home and the risk of asthma and 
allergic rhinitis; notably, the concentration of 
diethyl  hexyl phthalate in indoor dust is associ-
ated with wheezing among preschool children 
(Bornehag et al. 2004; Kolarik et al. 2008). 
These findings may be relevant when the 
increase in the prevalence of allergic and auto-
immune diseases in the industrialized countries 
over the last decades is taken into consideration 
(Asher et al. 2006). 
Endocrine-disrupting chemicals (EDCs) 
are commonly found in the environment 
and originate from industrial and agricul-
tural sources, including plant constituents, 
pesticides, and chemicals used in the plastics 
industry and in consumer products. Although 
the molecular mechanisms of EDC effects 
have not been defined, accumulated studies 
have revealed that EDCs can act via multiple 
mecha  nisms of action (Tabb and Blumberg 
2006). Endocrine-disrupting effects are 
thought to be mediated, in part, by mimicking 
or blocking the action of the steroid hormones 
through both nuclear receptor–dependent and 
nonreceptor-dependent mechanisms, leading 
to differential target-gene transcription (Fisher 
2004; Tabb and Blumberg 2006) and affecting 
not only the endocrine or reproductive systems 
but also the immune system (Ahmed 2000; 
Chalubinski and Kowalski 2006). Indeed, the 
results from in vitro and in vivo animal models 
have indicated that EDCs may act as immune 
modulators exerting their adjuvant effects at 
different levels of the immune regulatory net-
work, including humoral immunity, cell sur-
vival, and cyto  kine synthesis (Chalubinski and 
Kowalski 2006). For example, nonyl  phenol 
(NP) and 4-octylphenol (4-OP), the break-
down products from domestic and industrial 
detergents, suppressed T-helper 1 (Th1) and 
enhanced Th2 cell develop  ment in a murine 
model (Kato et al. 2006). Environmentally 
relevant doses of tributyltin, another nota-
ble environmental pollutant, also promoted 
strong Th2 polarization and exacerbated 
antigen-induced airway inflammation in mice 
(Kato et al. 2004). These findings, together 
with the documented trans  generational effect 
of EDCs through epigenetic modifications 
(Anway et al. 2006), raise the possibility that 
EDCs such as NP and 4-OP may have signifi-
cant impact on the genesis and the progression 
of host immunity. 
Dendritic cells are primary and potent 
antigen-presenting cells with a critical role 
in initiation and progression of innate and 
adaptive immunity (Banchereau et al. 2000; 
Shortman and Liu 2002). Their strategic loca-
tion throughout peripheral tissues and their 
role in surveillance for antigen exposure sug-
gest that they are likely a target for EDCs; in 
fact, dendritic cells are able to extend dendrites 
into the lumen, presumably for sampling 
antigen (Rescigno et al. 2001). However, at 
present, it is unknown whether EDCs have 
any direct effect on human myeloid dendritic 
cells (mDCs). Considering the importance 
of mDCs in various disease contexts, we 
investigated the in vitro effects of two com-
mon EDCs, NP and 4-OP, on the generation 
of two regulatory cytokines, tumor necrosis 
factor-α (TNF-α) and inter  leukin (IL)-10, 
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Ba c k g r o u n d: Exposure to environmental endocrine-disrupting chemicals (EDCs) is often 
  associated with dysregulated immune homeostasis, but the mechanisms of action remain unclear. 
oBjectives: The aim of this study was to test a hypothesis that EDCs regulate the functions of 
human dendritic cells, a front-line, immunoregulatory cell type in contact with the environment. 
me t h o d s : We investigated circulating myeloid dendritic cells (mDCs) from five subjects and meas-
ured their responses, with or without coculture with autologous T cells, to two common EDCs, 
nonylphenol (NP) and 4-octylphenol (4-OP). EDC-associated cytokine responses, signaling events, 
and histone modifications were examined using ELISA, Western blotting, and chromatin immuno-
precipitation (ChIP) assays, respectively. 
re s u l t s: In all cases, mDCs treated with NP or 4-OP demonstrated increased expression of tumor 
necrosis factor-α (TNF-α) but decreased baseline and lipopolysaccharide (LPS)-induced (inter  leukin) 
(IL)-10 production; the increase in TNF-α was partially reversible by an estrogen receptor (ER) 
antagonist. Activation of the MKK3/6-p38 signaling pathway marked the effect of NP on TNF-α 
expression, concomitant with enhanced levels of methyltranferase complex [mixed-lineage leukemia 
(MLL) and tryptophan-aspartic acid repeat domain 5 (WDR5)] in the nucleus and of trimethylated 
H3K4, acetylated H3, and H4 at the TNFA gene locus. Further, up-regulated TNF-α expression 
was significantly suppressed in NP-treated mDCs by a histone acetyltransferase inhibitor. In the 
presence of NP-treated mDCs, T cells showed increased levels of IL-13 but decreased expression of 
interferon-γ.
co n c l u s i o n s: These results suggest that NP and 4-OP may have functional effects on the response 
of mDCs via, in part, the ER, MKK3/6-p38 MAPK signaling pathway, and histone modifications, 
with subsequent influence on the T-cell cytokine responses.
key w o r d s : dendritic cell, endocrine-disrupting chemical, epigenetic, mixed-lineage leukemia, 
MLL, nonylphenol. Environ Health Perspect 118:67–72 (2010).  doi:10.1289/ehp.0901011 avail-
able via http://dx.doi.org/ [Online 28 August 2009]Hung et al.
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in human mDCs, as these two cyto  kines are 
important in pro- and anti-inflammatory 
processes, respectively (Asadullah et al. 2003; 
Mukhopadhyay et al 2006). The results herein 
provide evidence supporting the influence of 
EDCs on the function of mDCs, involving, 
in part, an estrogen receptor (ER)-dependent 
mechanism and activation of mitogen- 
activated protein kinase (MAPK), with subse-
quent modifications of histone structures asso-
ciated with TNF-α expression in mDCs.
Materials and Methods
Isolation and analysis of mDCs. A total of 
five volunteer subjects were enrolled in this 
study, with a mean age of 33.2 years (range, 
20–50 years). The study of human subjects 
was approved by the Institutional Review 
Board of Kaohsiung Medical University, and 
informed consent was obtained from each 
subject before blood samples were collected. 
Peripheral blood mono  nuclear cells (PBMCs) 
were isolated, and circulating mDCs were 
magnetically sorted using blood DC anti-
gen (BDCA-1) cell isolation kits (Miltenyi 
Biotec, Bergisch Gladbach, Germany), fol-
lowing the manufacturer’s instructions. In all 
cases, the purity of isolated mDCs was > 90%. 
Purified mDCs (2 × 105 cells/condition) were 
treated with 0.2 µg/mL lipo  poly  saccharide 
(LPS; from Escherichia coli, L0127:B8; Sigma, 
St. Louis, MO, USA), varying doses of NP or 
4-OP, or a combination of LPS plus NP or 
OP and evaluated after various time points. 
Media alone was used as the control, and 
17β-estradiol (E2; 10 µM, Sigma) was used in 
parallel cultures for comparison. To examine 
the involvement of the ER axis, we pretreated 
mDCs with an ER antagonist, ICI182,780 
(10 µM; Sigma), 1 hr before treating the 
cells with NP or 4-OP. In some cases, after 
1 hr treatment with 1 µM of one of three 
MAPK inhibitors (PD98059, SB203580, and 
SP600125; Sigma) and an IκB-α phospho-
rylation inhibitor, BAY11-7082, mDCs were 
stimulated with NP. To evaluate the effect of 
histone acetylation on TNF-α production, 
mDCs were treated with varying doses of 
anacardic acid (Calbiochem, San Diego, CA, 
USA), a histone acetyl  transferase inhibitor. 
The production of cytokines in the culture 
supernatants was determined by ELISA (R&D 
Systems, Minneapolis, MN, USA) for IL-10 
and TNF-α. 
Cytosolic and nuclear protein extrac-
tion. We treated 1 × 106 mDCs with LPS 
(0.2 µg/mL), NP, or a combination of LPS 
plus NP for 1 hr and washed with ice-cold 
phosphate-buffered saline once and then 
resuspended. The cells were lysed in 10 mM 
HEPES, pH 7.9; 1.5 mM MgCl2; 10 mM 
KCl; 300 mM sucrose; 0.5% NP-40; and 
proteinase inhibitor cocktail (1.0  mM 
phenylmethane  sulfonyl fluoride, 1.0 mM 
EDTA, 1 µM pepstatin A, 1 µM leupeptin, 
and 1 µM aprotinin) for 3 min on ice, then 
centrifuged at 6,500 rpm for 20 sec.
The super  natants were then collected for 
cytosolic protein analysis. The precipitants 
were resuspended using 20 mM HEPES, pH 
7.9; 1.5 mM MgCl2; 420 mM NaCl; 1 mM 
dithiothreitol (DTT); 0.2 mM EDTA; 25% 
glycerol; and proteinase inhibitor cocktail on 
ice for 30 min, then centrifuged at 12,000 rpm 
for 5 min. The supernatants (nuclear lysate) 
were diluted with an equal amount of 20 mM 
HEPES, pH 7.9; 10 mM KCl; 1 mM DTT; 
0.2 mM EDTA; 25% glycerol; and proteinase 
inhibitor cocktail.
Western blotting. For Western blotting 
analysis, mDCs were treated with LPS (0.2   
µg/mL), NP, or a combination of LPS plus 
NP for 1 hr and then lysed. Equal amounts of 
whole-cell lysates were analyzed by Western 
blotting with various anti  bodies, including anti-
p65, antiphospho-p65 (pp65), anti-MKK-3/6, 
antiphospho-MKK3/6, anti-MAPKp38, and 
antiphospho-p38 antibodies (all from Santa 
Cruz Biotechnology, Santa Cruz, CA, USA). In 
some cases, nuclear extracts were obtained from 
1 × 106 mDCs stimulated with NP or 4-OP 
(10–8 M) for 1 hr and analyzed by Western 
blotting with anti–mixed-lineage leukemia   
(MLL) and anti-tryptophan-aspartic acid 
repeat domain 5 (WDR5) anti  bodies (Upstate 
Biotechnology, Waltham, MA, USA). 
Immunoreactive bands were visualized using 
horseradish peroxidase-conjugated secondary 
antibodies and the enhanced chemilumines-
cence (ECL) system (Amersham Pharmacia 
Biotech, Uppsala, Sweden). 
Stimulation of CD4+ T cells by mDCs and 
analysis of T-cell cytokines. We purified CD4+ 
T cells from PBMCs from the study subjects, 
using CD4 magnetic beads (Miltenyi Biotec) 
according to the manufacturer’s instructions. 
After treating the cells with medium alone or 
NP for 2 days, mDCs were cocultured with 
isolated CD4 T cells (1:10; a predetermined 
ratio for optimal cytokine analysis) for 5 days. 
Cell supernatants were collected for analysis 
of IL-13 and interferon-γ (IFN-γ) levels by 
ELISA assay. 
Chromatin immunoprecipitation assay 
(ChIP). We performed ChIPs as described 
previously (Lee et al. 2003) with minor modi-
fications: 5 × 105 cells were treated with 1% 
formaldehyde for 10 min at room tempera-
ture, followed by sonication of DNAs and 
immuno  precipitation of chromatins over-
night with antibodies for tri  methylated H3K4 
and acetylated histone H3 and H4 (Upstate 
Biotechnology, Temecula, CA, USA). Immune 
complexes were collected using a protein A 
slurry (Invitrogen, Carlsbad, CA, USA), and 
the DNA was reverse cross-linked, extracted, 
Figure 1. Effects of NP and 4-OP on production of TNF-α (A,B,C,F) and IL-10 (D,E) in mDCs evaluated at 
different time points after the initiation of the culture. (A,B) Levels of TNF-α after treatment with varied 
concentrations of NP (A) or 4-OP (B) at four time points. (C,E) Levels of TNF-α (C) and IL-10 (E) induced by 
0.2 µg/mL LPS in mDCs in the presence or absence of 10–8 M NP at 48 hr. (D) Levels of IL-10 after treatment 
with NP or 4-OP for 48 hr. (F) Kinetic expression of TNF-α in mDCs treated with 10–8 M NP in the presence 
or absence of anti-IL-10 Ab. Data represent five independent experiments.
*p < 0.05 compared with untreated cells in A, B, D, and F. 
1,400
1,200
1,000
800
600
400
200
0
1.6
1.2
0.8
0.4
0
6
5
4
3
2
1
0
1,400
1,200
1,000
800
600
400
200
0
450
300
150
1,000
800
600
400
200
0
0
4
* * *
* *
*
* *
*
* *
*
*
*
*
*
*
*
* * *
12
Time point (hr) Time point (hr)
T
N
F
-
α
 
(
p
g
/
m
L
)
T
N
F
-
α
 
(
n
g
/
m
L
)
T
N
F
-
α
 
(
p
g
/
m
L
)
T
N
F
-
α
 
(
p
g
/
m
L
)
I
L
-
1
0
 
(
p
g
/
m
L
)
I
L
-
1
0
 
(
n
g
/
m
L
)
24
Control Control LPS
*
*
*
*
* *
*
LPS + NP  NP
LPS LPS + NP  NP  NP  NP + anti-IL-10  Control  Control
*
* * *
* * *
*
NP [M] 4-OP [M]
10–10 10–10 10–9 10–9 10–8 10–8 10–7 10–7
48 4 12 24 48
Control
10–10 M NP
10–9 M NP
10–8 M NP
Control
10–10 M 4-OP
10–9 M 4-OP
10–8 M 4-OP
4 hr
12 hr
24 hrEffects of EDCs on human mDCs
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 1 | January 2010  69
and quantified on a Taqman SDS 7900HT 
(Applied Biosystems, Foster City, CA, USA). 
For polymerase chain reaction (PCR) ampli-
fication of ChIP products, primers and probes 
were designed to analyze the proximal pro-
moter and intronic enhancer regions of the 
TNFA gene as previously described (Sullivan 
et al. 2007), encompassing the following sub-
regions relative to the transcription start site: 
TNF1 (+99 to –42); TNF2 (+32 to –119), 
TNF3 (–100 to –250), TNF4 (–195 to –345), 
and +1417, +720, and –1700. PCRs were 
run on the ABI 7700 Taqman thermocycler 
(Applied Biosystems). The relative intensities 
of the amplified products were normalized to 
the input DNAs as previously described (Lee 
et al. 2003; Sullivan et al. 2007).
Statistical analysis. All data are presented 
as mean ± SD. Changes in cytokine levels 
were analyzed by using the Wilcoxon signed 
rank test. Differences between experimental 
and control groups were analyzed using the 
Mann–Whitney test. We consider a p-value 
< 0.05 to indicate significant between-group 
differences.
Results
NP and 4-OP modulate TNF-α and IL-10 
levels in mDCs. To examine the potential 
effect of NP and 4-OP on the expression of 
cytokines in mDCs, we treated mDCs with 
varying doses (10–10–10–7 M) of NP or 4-OP 
either alone or in combination with LPS 
(0.2 µg/mL) and evaluated cells at 4, 12, 24, 
and 48 hr after the initiation of the culture. 
The results showed that treatment of mDCs 
with either NP or 4-OP alone revealed sig-
nificantly increased levels of TNF-α produc-
tion, even at the lowest dose tested (10–10 M; 
Figure 1A,B). When LPS was added to the 
culture, there was a significant additive effect 
on the expression of TNF-α (Figure 1C). In 
contrast, NP and 4-OP appear to have an 
inhibitory effect on the expression of IL-10 
(Figure 1D); although mDCs at resting stage 
without stimulation showed low but detect-
able levels of IL-10 expression, both NP and 
4-OP inhibited the baseline level of IL-10. As 
expected, LPS induced a significant level of 
IL-10 production, but in the presence of NP, 
we found significantly reduced levels of LPS-
induced IL-10 (Figure 1E). Moreover, the 
expression of TNF-α in mDCs treated with 
10–8 M NP was further increased when neu-
tralizing anti-IL-10 (0.1 µg/mL) anti  bodies 
were added to the culture, suggesting that 
NP-enhanced TNF-α expression appeared, in 
part, because of NP’s effect on the suppression 
of IL-10 expression (Figure 1F). During this 
culture period, there was no significant differ-
ence in the expression levels of DC matura-
tion markers, including CD86, CD80, and 
HLA-DR, as judged by flow cytometry (data 
not shown). 
NP increased TNF-α production in mDCs 
partly via the ER. Because EDCs are able to 
serve as inflammatory inducers partly via the 
ER (Tabb and Blumberg 2006), we examined 
whether ER was involved in the regulatory 
activity of NP and 4-OP in mDCs. As shown 
in Figure 2A, the addition of an ER antago-
nist, ICI182,780, was able to partially suppress 
the levels of NP-induced TNF-α expression 
in mDCs. Moreover, mDCs treated with E2 
showed increased levels of TNF-α produc-
tion, and the addition of ICI182,780 receptor 
antagonist inhibited the induction of TNF-α 
expression (Figure 2A). These results suggested 
that NP-induced TNF-α expression in mDCs 
was, at least in part, mediated through the 
ER. However, ICI182,780 appeared to be 
incapable of blocking the suppressive effect of 
NP on IL-10 expression in mDCs, suggest-
ing that NP-induced IL-10 expression may 
be an ER-independent pathway in mDCs 
(Figure 2B).
NP increased TNF-α production in 
mDCs via the MKK 3/6-p38 MAPK pathway. 
Next, to investigate the NP-induced signal-
ing events, we examined the effects of MAPK 
and NF-κB (nuclear factor kappa-B) inhibi-
tors on NP-induced TNF-α expression in 
mDCs. Figure 3A shows that the addition of a 
p38-MAPK inhibitor (SB203580) suppressed 
NP-induced TNF-α expression, whereas other 
inhibitors—SP600125 (for JNK), PD98059 
(for MEK1/ERK), and BAY11-7082 (for 
NFκB p65)—showed no significant inhibitory 
effect. Moreover, Western blot analyses of 
NP-treated or 4-OP–treated mDCs showed 
that, similar to the effect of LPS stimulation, 
EDC-treated mDCs demon  strated increased 
levels of phosphorylated p38 MAPK and 
MKK3/6 (Figure 3B); MKK3/6 serves as 
upstream signaling molecules of MAPKp38 
(Hommes et al. 2003). No significant enhance-
ment of phosphorylated NF-κB p65 was 
observed in NP-treated cells (data not shown). 
These results suggest the involvement of the 
MKK 3/6-p38 signaling pathway in NP’s effect 
on the induction of TNF-α expression. 
EDC-mediated histone modifications at the 
TNFA gene locus. The expression of TNF-α 
is regulated in a complex network of molecu-
lar events, wherein epi  genetic modifications 
occur both develop  mentally and in response 
to acute stimulation (Lee et al. 2003; Sullivan 
et al. 2007). In particular, recent evidence from 
analyses of monocytes and macrophages has 
shown that acetylated H3 and H4, together 
with trimethylated H3 lysine 4 (H3K4), mark 
active transcription in the TNFA gene locus 
(Sullivan et al. 2007). To examine whether 
the TNFA gene locus underwent histone 
modifications in mDCs as the result of the 
EDC treatment and MAPK activation, we per-
formed ChIP analyses of mDCs treated with 
NP, using PCR primers corresponding to four 
overlapping subregions (–1700 and TNF1–4, 
covering the region between –345 and +99) in 
the TNFA promoter and two intronic regions 
(+720 and +1417) of the TNFA gene. Results 
Figure 2. The regulatory activity of NP on cytokine expression is mediated, in part, via the ER. The levels 
of TNF-α (A) and IL-10 (B) in NP (10–8 M)-treated mDCs in the presence or absence of an ER antagonist, 
ICI182,780 (10 µM); 10 µM E2 was used in parallel cultures for comparison. NS, not significant. Data represent 
five independent experiments. 
*p < 0.05. 
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showed that compared with those found in 
medium control cultures, significant histone 
modifications at the TNFA gene locus were 
present in NP-treated mDCs. As shown in 
Figure 4A, up-regulatedd TNF-α expres-
sion in NP-treated mDCs was accompanied 
by an increased level of histone 3 acetylation 
primarily in the intron sequence (+1417) of 
the TNFA gene, whereas increased histone 4 
acetylation was associated predominantly with 
the proximal promoter regions of the TNFA 
gene (Figure 4B). In fact, the involvement of 
histone acetylation in the expression of TNF-α 
was further supported by the findings that the 
addition of a histone acetyltransferase inhibitor, 
anacardic acid, yielded significant suppression 
of TNF-α expression in NP-treated mDCs 
(Figure 4C). 
Moreover, ChIP analyses also revealed 
increased levels of trimethylated H3K4 at the 
proximal promoter subregion, TNF3, and an 
intronic region (+720) of the TNFA gene in 
NP-treated cells (Figure 5A). Trimethylation 
of H3K4 involves a sequential event from the 
initial recruitment of a methyltransferase com-
plex, including a methyltransferase, MLL, and 
WDR5 protein scaffold, which in turn medi-
ates dimethylation to tri  methylation conver-
sion of histone H3 at K4 (Dou et al. 2006). 
Therefore, we next evaluated whether NP 
and 4-OP could also influence nuclear MLL 
and WDR5 expression using Western blot 
analysis. Levels of MLL and WDR5 in the 
nuclear fractions of NP-treated mDCs were 
significant compared with those of medium 
controls (Figure 5B). These findings suggested, 
therefore, that the effects of NP and 4-OP 
are associated with their abilities in mediating   
differential histone modifications. 
NP-treated mDCs enhanced IL-13 pro-
duction and suppressed IFN-γ production in 
T cells. We examined whether NP-treated 
mDCs influenced the cytokine responses in 
T cells. CD4+ T cells purified from PBMCs 
of the study subjects were cocultured with 
NP-treated or 4-OP–treated mDCs for 
5 days. Cell supernatants were collected for 
IL-13 and IFN-γ measurement. IL-13 produc-
tion in T cells was significantly increased after 
coculture with NP-treated and 4-OP–treated 
mDCs (Figure 6A), whereas IFN-γ production 
was suppressed in treated mDCs (Figure 6B). 
These data suggest that NP-treated or 
4-OP–treated mDCs may affect the T-cell 
cyto  kine responses toward a Th2 phenotype 
after stimu  lation. 
Discussion 
Dendritic cells have been recognized as a 
chief orchestrator of immune responses, and 
mDCs exert their regulatory functions, in part, 
through the release of cytokines after activa-
tion and/or inflammatory insults (Shortman 
and Liu 2002; Soumelis and Liu 2006). In 
the present study, we found that two com-
mon EDCs, NP and 4-OP, target and regulate 
cytokine responses of dendritic cells through 
mechanisms involving MAPK activation and 
histone modifications, suggesting the existence 
of an EDC–dendritic cell axis in the regulation 
of dendritic cell function and the subsequent 
T-cell responses. Results from recent epide-
miologic and experimental studies have sug-
gested the potential importance of exposure to 
EDCs in modifying the immune homeo  static 
state. Thus, understanding the targeting and 
regulatory pathways of EDCs, particularly in 
dendritic cells, would help in advancing the 
state of knowledge about EDC involvement in 
the development of immunologic diseases. 
EDCs undergo significant bioaccumula-
tion (Lalah et al. 2003), and various forms 
of metabolites can be detected in plasma 
and urine samples, the levels of which have 
served as a reference for estimating the levels 
of exposure. In a survey of subjects in New 
Zealand, Thomson et al. (2003) reported 
the plasma concentration of alkyl phenol of 
about 0.32 µg/L, which is between 10–9 M 
and 10–8 M. Also, in a study of 394 adults 
in the United States, Calafat et al. (2005) 
detected NP in 51% of samples, with lev-
els ≥ 0.1 µg/L; the median and 95th per-
centile concentrations were < 0.1 µg/L and 
1.57 µg/L, respectively. In the present study, 
the effective concentrations of NP and 4-OP 
for modulation of TNF-α expression were 
within the range of estimated exposure levels. 
The metabolism of NP is complex and yields 
a wide array of metabolites, thus decreasing 
the relative amounts of NP in the test urine 
samples. In fact, only 10% of ingested NP 
is excreted in the urine as NP or conjugated 
NP (Muller et al. 1998). Therefore, currently 
available data on exposure levels inferred from 
the measurement of NP in urine samples may 
represent only a small fraction of the NP that 
actually constitutes exposure. Moreover, given 
the known bioaccumulative effects of NP, the 
potential influence on dendritic cell function 
in vivo is likely to be greater.
In addition, our results showed that treat-
ment of mDCs with NP or 4-OP resulted in 
preferential activation of the MKK 3/6-p38 
MAPK pathway and differential effects on 
cytokine expression, associated with enhanced 
histone modifications at the TNFA gene 
locus. Also, NP and 4-OP inhibited the pro-
duction of IL-10 but increased TNF-α pro-
duction by mDCs, whereas ICI182,780, an 
ER antagonist, could reverse, at least in part, 
NP-induced TNF-α expression, suggesting 
the involvement of ER and MAPK activa-
tion in mediating NP’s effect. Further, the 
addition of a histone acetyl  transferase inhibi-
tor ablated the induction of TNF-α expres-
sion by NP. These results are consistent with 
the likelihood of ER-mediated chromatin 
remodeling in initiating gene transcription. 
However, ICI182,780 was unable to reverse 
the suppressive effect of NP and E2 on IL-10 
expression in mDCs. Although the nature of 
this ER-independent mechanism is unclear 
at present, it has been shown that 4-OP has 
a functional effect on the activity of the aryl 
hydro  carbon receptor, an independent recep-
tor (Bonefeld-Jørgensen et al. 2007). Further, 
NP is able to stimulate gene transcription 
mediated by the pregnane X receptor (PXR; a 
member of the nuclear receptor superfamily) 
(Masuyama et al. 2000), through its inter-
action with PXR, thereby facilitating the 
receptor-coactivator interaction. It is tempt-
ing to speculate that NP- (or 4-OP)-mediated 
TNF-α expression in mDCs may involve 
these two additional nuclear receptors. In 
addition, there is still a possibility that simi  lar   
Figure 4. Involvement of histone acetylation in the regulatory effect of NP on TNF-α expression. ChIP analyses of the relative levels of acetylated H3 (AcH3; A) 
and acetylated H4 (AcH4; B) at the TNFA gene locus encompassing the following subregions relative to the transcription start site: TNF1 (T1; +99 to –42); TNF2 
(T2; +32 to –119), TNF3 (T3; –100 to –250), TNF4 (T4; –195 to –345), +1417, +720, and –1700. The relative levels were normalized to the input DNAs and are shown 
as mean ± SD of five study subjects. (C) TNF-α expression levels in 10–8-M NP–treated mDCs in the presence or absence of varying doses of a histone acetyl-
transferase inhibitor, anacardic acid (AA). 
*p < 0.05 compared with NP treatment alone.
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to other EDCs, NP and 4-OP may regulate 
hormonal responses by directly modu  lating 
cell-signaling pathways rather than interacting 
with hormone receptors (Tabb and Blumberg 
2006). Cellular response to E2 may be medi-
ated both by ER binding to the estrogen 
response element and by non  nuclear actions 
such as activation of signal-transducing path-
ways (ER independent) (Guo et al. 2006). 
It is particularly relevant that the suppressive 
effect of E2, NP, and 4-OP on the expression 
of IL-10 appears to be independent of the ER, 
suggesting the existence of alternative pathways. 
Moreover, our data showed that NP and 4-OP 
had a dose-independent effect on the expres-
sion of TNF-α. The reason is unclear at pres-
ent, but this dose-independent phenomenon 
is not without precedents (Bevan et al. 2006; 
Bonefeld-Jørgensen et al. 2007), and suggests a 
rather complex mechanism operative in EDC’s 
effect on dendritic cells. Further detailed work 
is clearly needed to address these issues.
Although the detailed mechanisms and the 
extent to which the modifications occur upon 
exposure to EDCs remain unclear, the evi-
dence provided here supports a role of EDCs 
in the regulation of mDC function through 
epi  genetic modulation on the expression of 
cyto  kines, adding a new dimension to the exist-
ing regulatory network in mDCs. Epigenetic 
modification at the TNFA gene locus results 
from a concerted and complex network of 
regulation involving DNA methyla  tion, his-
tone modification, and chromatin remodeling. 
As has been noted in analysis of monocytes 
and macrophages (Sullivan et al. 2007), the   
present study showed that variable patterns 
of histone modifications were observed, and 
the primary regulatory regions associated with 
histone modifications could be identified in 
NP-treated mDCs. This variability may be 
due, in part, to the different levels of baseline 
and NP (or 4-OP)-induced TNF-α expres-
sion among the five subjects studied. Further 
study of additional subjects and detailed 
investigation with emphasis on defining the 
epigenetic mechanisms associated with EDC 
function would be important in defining the 
molecular basis of the involvement of EDCs 
in regulating immune response. An addi-
tional question that remains to be addressed 
is whether differential sensitivity of mDCs 
can be found between, for example, allergic 
versus non  allergic subjects, and our current 
studies would provide an experimental basis 
for addressing this possibility.
The use of plasticizers and the levels of 
their derivatives in the environment as EDCs 
have been increasing since World War II, 
and, incidentally, we have also witnessed an 
increase in prevalence of both auto  immune 
and allergic diseases (Asher et al. 2006). 
Although the exact cause for the increased 
prevalence is uncertain, the importance of 
environmental factors has been increasingly 
appreciated. One intriguing hypothesis has 
been the so-called hygiene hypothesis, which 
suggests that a lack of microbial exposure 
during critical periods in infancy increases 
the risk of allergic disease (Wills-Karp et al. 
2001). Although not mutually exclusive, 
other hypotheses are equally plausible (Platts-
Mills et al. 2005): The increased prevalence of 
allergic disease could be attributable to new 
immune adjuvant factors, for example, expo-
sure to environmental pollutants such as diesel 
fuel exhaust particles and EDCs (Chalubinski 
and Kowalski 2006). The results of the pres-
ent study would lend further support for this 
possibility. Furthermore, recent discover-
ies regarding aryl hydrocarbon receptor and 
environ  mental toxicant interaction and its 
influence on the balance of regulatory T and 
Th17 cells (Quintana et al. 2008; Veldhoen 
et al. 2008) highlight the potential impor-
tance of environmental exposure of various 
chemical pollutants and the development of 
immunologic diseases.
In summary, this study presents evidence 
supporting a role of NP and 4-OP in modula-
tion of dendritic cell function through their 
ability to enhance TNF-α but suppress LPS-
induced IL-10 expression. This effect involves 
the MKK3/6-p38 MAPK signaling pathway 
and histone modifications, leading to differen-
tial T-cell cytokine responses. TNF-α induces 
acute-phase response protein and plays an 
important role in the expression of inflamma-
tory responses, whereas IL-10 is recognized 
primarily as an anti-inflammatory cytokine. 
Therefore, the functional effect of NP and 
4-OP in inducing TNF-α, a proinflamma-
tory cytokine, while decreasing IL-10 produc-
tion in mDCs, suggests its proinflammatory 
function. Furthermore, NP-treated mDCs are 
able to polarize to a Th2 condition, suggest-
ing a potential role of NP and 4-OP in the 
expression of allergic diseases. Although NP 
and 4-OP are common representative EDCs 
and their chemical structures are similar, the 
observed phenomena of NP and 4-OP may 
be results of the influence of specific categories 
of EDCs but not universal action of EDCs in 
general. Evaluation of additional EDCs is also 
important for further study.
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